Chemical Compound

Ibrutinib

CAS Registry Number 936563-96-1
Back to search Request a Quote
Ibrutinib chemical structure
Primary Record

Ibrutinib

In stock
7,806 g
Purity
98.3 %
CAS
936563-96-1

Compound Identifiers & Properties

CAS
936563-96-1
PubChem CID
24821094
SMILES
C=CC(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Canonical SMILES
C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1

Names & Synonyms

  • Ibrutinib
  • 936563-96-1
  • IMBRUVICA
  • PCI-32765
  • ibrutinibum
  • Ibrutinib (PCI-32765)
  • Ibrutinib [USAN]
  • Imbruvica (TN)
  • PCI 32765
  • Ibrutinib (Standard)
  • Ibrutinib, Free Base
  • Ibrutinib [USAN:INN]
  • PCI-32765 (Ibrutinib)
  • 1X70OSD4VX
  • IBRUTINIB [INN]
  • IBRUTINIB [JAN]
  • RefChem:57737
  • UNII-1X70OSD4VX
  • IBRUTINIB [MI]
  • Ibrutinib (JAN/USAN)
  • Ibrutinib Intermediate 2
  • PCI32765
  • IBRUTINIB [VANDF]
  • CRA-032765
  • C25H24N6O2
  • Ibrutinib/PCI-32765
  • Pc-32765
  • D09KTS
  • Ibrutinib (BTK inhibitor)
  • IBRUTINIB [WHO-DD]
  • Ibrutinib (PCI32765)
  • Ibrutinib(PCI-32765)
  • Imbruvica; PCI-32765
  • JNJ 02
  • PCI-32765(Ibrutinib)
  • MFCD20261150
  • CHEBI:76612
  • MLS006010041
  • SCHEMBL201859
  • BTK Inhibitor PCI-32765
  • DTXSID60893450
  • Ibrutinib - Bio-X trade mark
  • GTPL6912
  • orb1307353
  • PCI-32765 (Ibrutinib)?
  • IBRUTINIB [ORANGE BOOK]
  • CHEMBL1873475
  • PCI-32765-00
  • HSDB 8260
  • EX-A066
  • L01XE27
  • XYFPWWZEPKGCCK-GOSISDBHSA-N
  • DTXCID601323465
  • GLXC-90098
  • CRA 032765
  • AMX10219
  • AMY27873
  • AOB87789
  • KS-000002KE
  • ABP000965
  • BBF-05894
  • BDBM50357312
  • EBC-11432
  • HY-10997R
  • NSC800769
  • ZINC35328014
  • AKOS022185476
  • C25-H24-N6-O2
  • (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
  • ACN-030256
  • AN-1333
  • CS-0015
  • DB09053
  • EBD2165770
  • EX-5960
  • FA34130
  • NSC-800769
  • QC-4573
  • NCGC00187912-01
  • NCGC00187912-02
  • NCGC00187912-03
  • NCGC00187912-12
  • NCGC00187912-17
  • NCGC00187912-18
  • AC-26942
  • AJ-91306
  • BI164531
  • BP-43643
  • CID:24821094
  • HY-10997
  • SC-96633
  • SMR004701213
  • SID:163679284
  • AB0008168
  • A3001
  • NS00072153
  • SW218096-2
  • X7513
  • EN300-97039
  • J2.980.554G
  • A11020
  • D10223
  • S-7810
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
  • A852882
  • C551803
  • F799864
  • A1-01649
  • Q5984881
  • BRD-K70301465-001-02-6
  • BRD-K70301465-001-05-9
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
  • 1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one
  • 2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-
  • Z1302446275
  • 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one
  • (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
  • (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one.
  • 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1- yl)prop-2-en-1-one
  • 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one
  • (R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-ylprop-2-en-1-one
  • 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
  • 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
  • 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
  • 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one; CRA 032765; Ibrutinib; Imbruvica; JNJ 02; PCI 32765; PCI 32765-00
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-2-propen-1-one
  • 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl]piperidino]-2-propene-1-one
  • 1-[3alpha-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine-1-yl]piperidine-1-yl]-2-propene-1-one
  • 1-{(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1- yl}prop-2-en-1-one
  • 1E8
  • 2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-
  • 805-642-2